Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TissueGene-C in Degenerative Arthritis
NCT01671072Phase 2Completed
- Sponsor
- Kolon Life Science Inc.
- Start
- Jul 2011
- Primary completion
- Oct 2012
- Modality
- Gene Editing, Gene Silencing, Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of Invossa in osteoarthritis (OA), sponsored by Kolon Life Science Inc.. Started Jul 2011; status: completed.
02
Drugs
Invossa
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01671072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01671072.